2016—2018年咸阳市中心医院中药注射剂的使用情况分析

目的 分析咸阳市中心医院中药注射剂的使用情况，为临床合理用药提供参考。方法 调取2016— 2018年咸阳市中心医院中药注射剂的用药数据，对中药注射剂的品种、销售金额、用药频度（DDDs）、日均费用（DDC）及销售金额排序（B）和DDDs排序（A）的比值（B/A）进行统计、排序和分析。结果 2016— 2018年咸阳市中心医院中药注射剂的销售金额逐年递减，品种构成相对稳定，以理血剂最多，其次为抗肿瘤类，其销售金额连续3年居于前2位；具体中药注射剂销售金额前10位的多为理血剂和抗肿瘤类药物，其中注射用丹参多酚酸盐的销售金额连续3年居于首位；舒血宁注射液、注射用血栓通、醒脑静注射液的DDDs连续3年居于前3位；在DDDs排名前10位的中药注射剂中，大多数品种的DDC在100元以下；大多数中药注射剂品种的B/A接近1，用药同步性较好。结论 咸阳市中心医院中药注射剂的使用基本合理，但仍存在一些问题，须继续加强管理。

Analysis on usage of traditional Chinese medicine injection in Xianyang Central Hospital from 2016 to 2018

Objective To analyze the usage of traditional Chinese medicine Injection (TCMI) in Xianyang Central Hospital, to provide references for clinical rational use of TCMI. Methods The medication data of TCMI in Xianyang Central Hospital from 2016 to 2018 were collected. Then varieties, consumption sum, defined daily dose system (DDDs), defined daily cost (DDC), and the ratio (B/A) of sequence of consumption sum (B) and sequence of DDDs (A) were statistically ranked and analyzed. Results Consumption sum of TCMI decreased year by year from 2016 to 2018. Varieties composition of TCMI were relatively stable, in which blood regulating drugs accounting for the largest proportion, followed by anti-tumor drugs. Consumption sum of blood regulating drugs and anti-tumor drugs ranked the top 2 in three consecutive years. The top 10 varieties ranked by consumption sum of single type were mainly in blood regulating drugs and anti-tumor drugs, among which Salvianolate for injection ranked the top in three consecutive years. DDDs of Shuxuening Injection, Xueshuantong for injection, and Xingnaojing Injection ranked the top 3 in three consecutive years. In DDDs of top 10 TCMI, DDC of most TCMI were less than 100. B/A values of most TCMI closed to 1, showing the synchronicity was better. Conclusion The application of TCMI in Xianyang Central Hospital is basically rational. However, there are still some problems, and the medication management should be strengthened.